Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of the Shear Stress Pattern Computed in Coronary Artery Reconstruction Models With and Without Side Branches in Predicting Plaque Progression.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Restrictive filling pattern of transmitral inflow in acute decompensated heart failure with preserved ejection fraction: insights from the KCHF registry.

Open heart·2026
Same author

Endothelial C-type natriuretic peptide/guanylyl cyclase-B signaling prevents pulmonary arterial hypertension.

Nature communications·2026
Same author

Association Between Achilles Tendon Thickness as Assessed by Ultrasound and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention.

Angiology·2026
Same author

Association of Dementia With the Outcome of Patients With Heart Failure: Evidence From the Japanese KCHF Registry.

Journal of the American Heart Association·2025
Same author

Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled Studies.

Thrombosis and haemostasis·2025

Related Experiment Videos

Antithrombotic Strategies After Complex Percutaneous Coronary Intervention.

Yasushi Ueki1, Koichiro Kuwahara1

  • 1Department of Cardiovascular Medicine, Shinshu University Hospital, Nagano 390-8621, Japan.

Journal of Clinical Medicine
|July 15, 2026
PubMed
Summary

Managing antithrombotic therapy after complex percutaneous coronary intervention (PCI) is crucial. Balancing ischemic and bleeding risks is key for optimal patient outcomes in these challenging revascularization cases.

Keywords:
anticoagulationantiplatelet therapybleedingpercutaneous coronary intervention

Related Experiment Videos

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Pharmacology

Background:

  • Complex percutaneous coronary intervention (PCI) is increasing due to aging populations and comorbidities.
  • Complex PCI involves challenging lesions like left main disease, chronic total occlusions, and severe calcification.
  • Antithrombotic therapy is vital post-PCI but poses a high bleeding risk in these patients.

Purpose of the Study:

  • To review current evidence and guidelines on antithrombotic therapy after complex PCI.
  • To discuss balancing ischemic and bleeding risks in patients undergoing complex PCI.
  • To provide clinical considerations for antithrombotic management post-complex PCI.

Main Methods:

  • Literature review of contemporary evidence.
  • Synthesis of current guideline recommendations.
  • Analysis of clinical considerations for antithrombotic therapy.

Main Results:

  • Complex PCI is a growing area of coronary revascularization.
  • Balancing ischemic and bleeding risks is paramount in antithrombotic selection.
  • Guideline recommendations shift focus from procedural complexity to risk stratification.

Conclusions:

  • Antithrombotic therapy requires careful management after complex PCI.
  • Risk-benefit assessment is essential for tailoring antithrombotic regimens.
  • Contemporary approaches prioritize individualized patient care over solely procedural factors.